Boundless Bio, Inc.
BOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $15 | $15 | $27 |
| Short-Term Investments | $103 | $112 | $123 | $126 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $2 | $2 |
| Total Curr. Assets | $120 | $130 | $140 | $154 |
| Property Plant & Equip (Net) | $48 | $49 | $50 | $51 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $49 | $50 | $51 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $169 | $179 | $191 | $206 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $1 |
| Short-Term Debt | $3 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $4 | $1 | $3 |
| Total Curr. Liab. | $12 | $9 | $6 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $47 | $48 | $48 | $48 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $50 | $49 | $48 |
| Total Liabilities | $59 | $57 | $55 | $56 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$247 | -$233 | -$217 | -$201 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $110 | $123 | $137 | $151 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $169 | $179 | $191 | $206 |
| Net Debt | -$12 | -$13 | -$15 | -$27 |